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Nihoyanno~on~os et al. (a) propose that lef2 vent~icn~a~ t~~ornb~ are 
responsible for reducing in-hospital mortality and late morbidity in 
patients with acute myocardial infarction. r hypothesis appears 
to have far-reaching consequences for the nosis, prognosis and 
management of left vent~cn~ar clots; however, ce~a~n questions 
remain to be answered before h ca 
The aMthorS claim Fhat ~~~Vi~~ have not examined the 
infhtence of thrombus formation on short- and long-term patient 
outcome. I would like to draw their attention to the studies by 
Spirit0 et al. (2) and f+iedman et al. (3) ofl t 
cance of left ventricular 
Nihoyannopoulos et al., S 
hospital morality rate is high in 
ular thrombi in the first 48 h after the onset of infarction in 
comparison with the rate in patients who develop t~rombi later or 
not at all. Spirit0 et al. attributed their ending to a larger infarct size 
and severe wall moFion abnormalities in the group with early 
thromb~. Because the present study detected t~~omb~ only after 48 h 
ute onset of infarction, the results cold be expected 
owever, even long-t results have shown poorer I 
rade ventr~cn~a~ ecto 
and a higher mortality rate in patients with t~r~rnb~ than in those 
without thrombi (2,3). Our e~~rience (41 is in keeping with that of 
Spirito et al. (2) and Friedman et al. (31 reins to wall motion 
score, left ventricular ejection fraction symptomatic saatus at 
the end of I and 6 months. 
Age, gender, Killip class and senrm creatine kinase isoenzyme 
(MB CK) levels were the only criteria used by the authors (I) to 
compare the ba~~ne risk of the patients in the two grouts. Because 
many more factor, cynical and ~nves~~tion~, dete~ine the p~gno- 
sis of patients with acute myocardi~i inaction (51, ~~e~nces in 
mortality between the two groups could have been related to factors 
other than the presence or absence of left ventricular thtombi. More- 
over, because morn@ IS related ?o the interplay of numerous vatia- 
bles, these two patie at groups, which did not differ sig~fic~tly on the 
basis of the univa~ate analysis ~~o~ed, may be found to have a very 
dierenb baseline risk of rnn~~ity if a rnnltivn~a~ analysis is per- 
formed that incorporates various mortality determinants. 
Left ventricular function, one of the most important factors 
affecting in-hospital mortality, was assessed on the basis of Killip 
class alone. However, a prognostic index based only on clinical 
examina~on has many limitations and cannot predict mortality with 
high accuracy (4). A better comparison between the two groups 
could have been made by using more sensitive and objective indexes 
of left ventricular function, such as left ventricular ejection fraction, 
cardiac index and wall motion score. 
Nihoyannopou~os et al. state that among the patients without left 
vent~cu~a~ tbromb~~ four died of a vent~cu~ar septat defect that was 
confirmed at autopsy. It would have been wo~~wh~~e if the authors 
had mentioned the cause of death in the remaining five patients 
without and in the two patients with thrombi. Oniy with this informa- 
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Dalvi is concerned that the consequences of following our sugges- 
tion that intraventricular thrombi after acute myocardinl infarction 
may have a protective effect are far-reaching for the management 
and prognosis of these patients. 
The main issue in the management of these patients is anticoag- 
ulant therapy. 1In this respect our findings are indeed similar to those 
of Friedman et al. and Spirit0 et al., who also found a very low 
incidence of systemic embolization after acute myocardial infarc- 
tion, an observation that seriously calls into question the need for 
anticoagulant therapy. 
We agree with Daivi at the determinants of pro~osis in 
infarction are rnn~tjp~e and are dominated by the extent of mylar- 
dial loss. We never inFended to propose that the presence of 
thrombus is in itself a good prognostic indicator. We believe that for 
comparable degrees of myocardial loss, all other prognostic indica- 
tors being equal, the presence of thrombus may have a bene~cial 
elect by ‘.spl~n?ing” the damaged wail. e studies by F~edman et 
al. and Spirito et al. included patients with aid my~ardia~ infarc- 
tion, a factor that potentially affects mortality in the study group, as 
Dalvi correctly mentions. In our study we excluded such patients, 
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maintaining as homogeneous a study group as possible, with similar 
age, gender ratio and infarct size. In this setting, I1 of the 12 patients 
who died had anterior mycrcardial infarction, but only 2 had mural 
thrombus and died of recurrent ischemia and myocardial infarction, 
while 9 others without thrombus died of cardiac rupture (4 patients), 
acute pump failure (3 patients) or recurrent ischemia and arrhythmia 
(2 patients). 
Dalvi draws attention to one imbortant point, that is, to the 
known difficulties in the assessment of myocardial infarct size in the 
acute phase. Perhaps echocardiography is one of the few techniques 
with acceptable patient safety and convenience to be used as a 
bedside test for assessing wall motion abnormalities. However, the 
objective quantification of myocardial infarction raises several prob- 
lems, and in our experience these problems principally relate to the 
assessment of abnormally moving segments in relation to whether 
the myocardium is irreversibly dead or whether it is simply jeopar- 
dized by potentially reversible ischemia. Thus, because of these 
problems, in the acute setting we chose clinical assessment-which 
in good hands is widely believed to be as accurate as any simple 
noninvasive determination-in association with creatine kinase lev- 
els. Furthermore, in our experience “eye-balling” overall left ven- 
tricular function and grading it in three categories (good, fair and 
poor) is as accurate as any digital technique. In applying this 
ciassification we found no differences between patients with and 
without thrombus. We found a significantly larger infarct size in 
patients with anterior than in patients with inferior infarction but no 
difference between those with anterior infarction with and without 
thrombus. The incidence of left ventricular aneurysm formation was 
also similar in the two groups. 
Finally, we are grateful to Dalvi for the opportunity to recapit- 
ulate our definite observation (seen also in the studies of Friedman 
et al. and Spirit0 et al.) that although the incidence of thrombus 
formation was high, that of embolic events was low. We are also 
grateful for the opportunity to recapitulate our hypothesis (which 
was clearly stated as such) that, for reasons of a perhaps mechanical 
nature, clot within the heart may not adversely affect prognosis :;nd 
irdeed iw help. Dalvi’s comments also help us to suggest a word 
of caution in applying active interventional policies, such as pre- 
scnbing anticoagulant agents automatically whenever intraventfic- 
ular thrombi are visualized (thus introducing an “imaging-induced 
disease”), until the broad range of clinical experience is reported 
and discussed. 
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This past wrek I took the Board Examination in Cardiovascular 
Diseases given by the American Board of Internal Medicine. As a 
*For the review, I used ACCEL Volumes 18-21. 1986-1989, and Learn- 
ing Center Highlights Volumes l-4, 1985-1989. Resource material produced 
by the American College of Cardiology may be obtained by calling Abe College 
(I-800-253-4636) or by writing to them at the following address: American 
College of Cardiology. 9111 Old Georgetown Road, Bethesda, Maryland 
20814 (ACCEL. Attn: Elizabeth Wilson; Learning Center, Attn: Janet Harry). 
